These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 317272)

  • 1. A study of T-lymphocytes and delayed cutaneous hypersensitivity reaction in patients with squamous cell carcinoma of head and neck region.
    Singh SN; Agrawal BM; Shanker R; Rajvanshi VS
    Indian J Cancer; 1979; 16(3-4):53-8. PubMed ID: 317272
    [No Abstract]   [Full Text] [Related]  

  • 2. [Peripheral T-lymphocytes and delayed hypersensitivity in surgically and radiologically treated patients with early stages of larynx-carcinoma].
    Behrens K; Sesterhenn K; Schütt A
    HNO; 1982 Jul; 30(7):250-5. PubMed ID: 6981631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck.
    Deegan MJ; Coulthard SW; Quaiman SJ; Schork MA
    Cancer Res; 1977 Dec; 37(12):4475-81. PubMed ID: 144562
    [No Abstract]   [Full Text] [Related]  

  • 4. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
    Bier J; Bitter K; Nicklisch U
    J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: a preliminary report.
    Rabin BS; Johnson J; Claassen D
    Laryngoscope; 1984 May; 94(5 Pt 1):688-90. PubMed ID: 6232437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological status of patients in carcinoma head and neck.
    Vasenwala SM; Aziz M; Rattan A; Ahmad KN
    Indian J Cancer; 1989 Sep; 26(3):137-44. PubMed ID: 2630426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck.
    Lundy J; Wanebo H; Pinsky C; Strong E; Oettgen H
    Am J Surg; 1974 Oct; 128(4):530-3. PubMed ID: 4429642
    [No Abstract]   [Full Text] [Related]  

  • 8. [Delayed skin reaction in head and neck cancer patient].
    Nagata M
    Nihon Jibiinkoka Gakkai Kaiho; 1983 Dec; 86(12):1478-86. PubMed ID: 6609230
    [No Abstract]   [Full Text] [Related]  

  • 9. Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy.
    Stefano S; Kerman R; Abbate J
    AJR Am J Roentgenol; 1976 Apr; 126(4):880-6. PubMed ID: 179361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck.
    Kim JW; Tsukishiro T; Johnson JT; Whiteside TL
    Clin Cancer Res; 2004 Aug; 10(15):5101-10. PubMed ID: 15297413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of immunocompetent cells in patients with head and neck squamous cell carcinoma.
    Dawson DE; Everts EC; Vetto RM; Burger DR
    Ann Otol Rhinol Laryngol; 1985; 94(4 Pt 1):342-5. PubMed ID: 3875306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunologic reactivity of breast cancer patients].
    Semiglazov VF; Kondrat'ev VB; Mar'enko AI; L'vovich EG; Sofronov BN
    Vopr Onkol; 1978; 24(8):74-9. PubMed ID: 695430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological approach in the evaluation of regional lymph nodes of patients with squamous cell carcinoma of the head and neck.
    Verastegui E; Morales R; Barrera JL; Müeller A; Guzman B; Meneses A; Alfaro G
    Clin Immunol; 2002 Jan; 102(1):37-47. PubMed ID: 11781066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic abnormalities in head and neck cancer.
    Eilber FR; Morton DL; Ketcham AS
    Am J Surg; 1974 Oct; 128(4):534-8. PubMed ID: 4422512
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of radiotherapy on cellular immunity of patients with head and neck cancers].
    Misaki T; Arai K; Konishi J; Abe M; Torizuka K; Makimoto K; Nesumi N
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2371-6. PubMed ID: 3494798
    [No Abstract]   [Full Text] [Related]  

  • 16. Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.
    Wells SA; Burdick JF; Joseph WL; Christiansen CL; Wolfe WG; Adkins PC
    J Thorac Cardiovasc Surg; 1973 Oct; 66(4):557-62. PubMed ID: 4755446
    [No Abstract]   [Full Text] [Related]  

  • 17. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique immunobiological aspects of head and neck squamous carcinoma.
    Chretien PB
    Can J Otolaryngol; 1975; 4(2):225-35. PubMed ID: 166742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor.
    Pak AS; Wright MA; Matthews JP; Collins SL; Petruzzelli GJ; Young MR
    Clin Cancer Res; 1995 Jan; 1(1):95-103. PubMed ID: 9815891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levamisole in squamous cell carcinoma of the head and neck.
    Olivari AJ; Glait HM; Guardo A; Califano L; Pradier R
    Cancer Treat Rep; 1979 Jun; 63(6):983-90. PubMed ID: 380804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.